Mounjaro®
Starting from £179.99/mo
Start journey Learn moreReviews of B12 injections for weight loss are plentiful online, but the clinical picture is more measured than many of them suggest. Vitamin B12 plays a genuine role in energy metabolism, yet no published trial has demonstrated that B12 injections cause meaningful weight loss in people who are not B12-deficient. The NHS does not recommend B12 injections as a weight-loss treatment, and no UK medicines regulator has licensed them for that purpose. Understanding why so many people report positive experiences — and what those experiences likely reflect — is worth doing properly before you spend money or make decisions based on reviews alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The honest starting point is what trials have and haven't found. B12 is an essential water-soluble vitamin involved in red blood cell formation, neurological function and the conversion of food into usable energy. When someone is genuinely deficient, correcting that deficiency with injections can produce a noticeable lift in energy and a reduction in fatigue. That experience is real, and it explains why reviews of B12 injections for weight loss so often describe feeling more active and motivated.
What those reviews rarely distinguish is whether any change in weight came from the B12 itself or from the person moving more, eating differently and feeling better in themselves. The NHS medicines guidance is clear that B12 is not a weight-loss treatment, and a systematic search of the published literature finds no robust randomised controlled trial demonstrating meaningful fat loss from B12 injections in adults with adequate B12 levels. A 2019 meta-analysis in the journal Nutrients found that B12 supplementation (in all forms) did not reduce body weight or BMI in participants who were not deficient. Reviews on commercial wellness sites draw conclusions that the trial record does not support.
That is not a reason to dismiss B12 entirely. Undiagnosed or subclinical deficiency is more common than many people realise, particularly in people following vegan or vegetarian diets, those over 60 and people taking long-term metformin. If your B12 is low, restoring it matters, and the subsequent energy improvement is legitimate. It just isn't the same as a licensed weight-loss medicine.
GLP-1 receptor agonists work through a completely different mechanism from anything B12 does. Tirzepatide (Mounjaro) activates two gut-hormone receptors (GIP and GLP-1) to reduce appetite, slow gastric emptying and improve blood-sugar regulation. Semaglutide (Wegovy) targets the GLP-1 pathway. Both carry UK licences specifically for weight management in eligible adults, granted by the MHRA following large phase-3 clinical trials. In the SURMOUNT-1 trial, tirzepatide produced an average body-weight reduction of around 20–21% over 72 weeks; the STEP 1 trial for semaglutide found an average reduction of approximately 15% over 68 weeks. These are published in the New England Journal of Medicine and form the evidence base NICE reviewed before recommending both medicines.
B12 injections have no equivalent evidence base for weight loss. They are not licensed for it, not recommended for it by any UK clinical body, and not subject to the same prescribing and monitoring framework. If you've been reading reviews of weight-loss injections more broadly, it's worth being clear on which type of injection the reviewer is actually describing, the terminology gets blurred in wellness content.
For a fuller picture of what injectable options currently exist and how they compare, our weight-loss injections overview covers the licensed field in plain terms.
Online reviews are self-selected. People who feel better after a course of B12 injections are more likely to write about it than those who felt no different. Reviews at wellness clinics are often gathered shortly after treatment begins, when any placebo effect or genuine deficiency correction is at its strongest. Many clinics bundle B12 injections with dietary advice, appetite-management coaching or other supplements, making it impossible to isolate the B12's contribution from everything else the person changed at the same time.
There is also a commercial dimension worth naming plainly. B12 injections are not prescription-only medicines in the same regulatory category as tirzepatide or semaglutide, which means they can be marketed and sold with fewer restrictions. A closer look at B12 weight-loss reviews specifically reveals patterns that are consistent with placebo and lifestyle confounding rather than a pharmacological weight-loss effect.
Scepticism here is not cynicism. It is the same standard a clinician applies before recommending a treatment, and it protects people from spending money on something unlikely to produce the outcome they need, when effective licensed options exist. If you want to understand how providers are evaluated more rigorously, reading a weight loss injection review from a source that applies clinical standards, rather than commercial ones, gives you a more reliable basis for comparison. Guidance on what to look for in a UK weight-loss injection provider is a useful reference point.
Start with your GP if you suspect a B12 deficiency, a blood test confirms it quickly, and treatment on the NHS is straightforward if deficiency is confirmed. That is the right route for B12.
If your goal is meaningful, clinically supported weight loss, the relevant treatments are tirzepatide and semaglutide, both of which require a prescription following a clinical assessment of your health history, current medicines and BMI. The NHS England guidance on weight-management injections explains the NHS eligibility criteria and the wraparound care they require. For many people those criteria are strict and the waiting lists are long, a regulated private pharmacy is the alternative route.
At nume, every consultation is reviewed by a GPhC-registered Independent Prescriber who reads your answers directly, on the same day. A real clinician looks at the full picture, not software running a checklist. If tirzepatide or semaglutide is clinically appropriate, treatment is dispensed from our own GPhC-registered pharmacy (registration 9012878) and arrives via tracked DPD delivery the next working day. You can also check what licensed weight-loss injections typically cost in the UK to set realistic expectations before you decide. Whether B12 reviews sent you here or something else did, the consultation is free and there is no obligation.
If you'd like to speak to our prescribers about whether licensed weight-loss treatment is right for you, start your free consultation here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.